ScholarIQanswers from OpenAlex

Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels

PaperCitations, authors & open-access status

Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels have?

ScholarIQcitation count

Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels has 93 citations in the OpenAlex counts ScholarIQ stores.

When was Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels published?

ScholarIQyear

Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels has 2015 year in the ScholarIQ index.

What is the open-access status of Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels?

ScholarIQoa status

Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels has closed oa status in the ScholarIQ index.

What is the DOI of Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels?

ScholarIQdoi

The DOI for Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels is on the source record.

What is the PMID of Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels?

ScholarIQpmid

The PMID for Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels is on the source record.

What is the OpenAlex record for Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels?

ScholarIQopenalex

The OpenAlex for Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial